Arturo Marti-Carvajal of the Venezuelan Branch of the Iberoamerican Cochrane Centre and colleagues in Spain and Greece have reviewed the evidence on the effects of homocysteine lowering treatments on cardiovascular disease. Jini Hetherington, from Cochrane Central Executive, describes what they found.